Krebsallianz visits partners in Moldova

Whilst visiting partners Coram Deo in Moldova, Krebsallianz receives great feedback and much gratitude for the donation of Paclitaxel. Patients are able to undergo their chemotherapy treatment with minimal discomfort or pain.

Breast cancer patients receive high quality chemotherapy

Breast cancer is the most prevalent cancer in women worldwide. In countries with advanced medical care the five-year survival of early stage breast cancers is 80–90 percent, falling to 24 per cent for breast cancers diagnosed at a more advanced stage.